InvestorsHub Logo
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

Re: guardiangel post# 24088

Monday, 07/21/2014 1:09:06 PM

Monday, July 21, 2014 1:09:06 PM

Post# of 30046
Like I stated earlier...William sold Provista Diagnostics a lung cancer test. If it wasn't LC Sentinel, which test was it? If you say LC Sentinel, then show me how William was able to sell Provista DX Onko-Sure? Where are the royalties? lol WolfPack

From the same article on my Moderator Sticky post

Radient has also begun rolling out a lung cancer screening kit called LC Sentinal in the US with partner, Provista Diagnostics. This kit was co-developed by the two companies and is based on the same technology as Onko-Sure. Provista intends to market the kit initially as a laboratory developed test, in which case, each individual laboratory using the kit will need to validate the test prior to its use. The companies will seek FDA approval for the kit in 2011; once this happens, kits can be marketed much more broadly without the need for validations from individual labs.

It should be noted that Radient is in the process of purchasing Provista Diagnostics, though the terms have not been finalized. The merger will provide Radient with full control of the LC Sentinal test along additional breast cancer and woman’s reproductive cancer tests. This is a natural fit considering the strong ties and synergies between the two companies.

******************************************************************
From the other article from my Moderator sticky post


Gold which Lung cancer test did William sell to Provista Diagnostics?

"Recently, Gartner sold Phoenix-based Provista Life Sciences LLC’s breast and lung cancer testing technologies to a new company called Provista Diagnostics Inc., which he intends to take public by the middle of next year."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.